Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EDOXABAN vs EFGARTIGIMOD ALFA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EDOXABAN vs EFGARTIGIMOD ALFA: Safety Overview

Metric EDOXABAN EFGARTIGIMOD ALFA
Total FAERS Reports 8,334 249
Deaths Reported 992 26
Death Rate 11.9% 10.4%
Hospitalizations 4,729 115
Average Patient Age 77.2 yrs 54.0 yrs
% Female Patients 46.5% 82.5%
FDA Approval Date Jan 8, 2015 N/A
Manufacturer Daiichi Sankyo Inc. argenx US
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription